Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People
Bloomberg Businessweek
00:00
Innovations in Diabetes and Weight Loss Treatments
This chapter explores the motivations behind pharmaceutical companies' innovations in drug delivery, focusing on the transition from injections to pill forms for weight loss and diabetes treatments. It discusses the competitive landscape among major companies and examines potential future applications for these new drug forms.
Transcript
Play full episode
